cancer stroma
Recently Published Documents


TOTAL DOCUMENTS

164
(FIVE YEARS 6)

H-INDEX

33
(FIVE YEARS 0)

2021 ◽  
Vol 27 (46) ◽  
pp. 7956-7968
Author(s):  
Michelle R Goulart ◽  
Konstantinos Stasinos ◽  
Rachel Elizabeth Ann Fincham ◽  
Francesca R Delvecchio ◽  
Hemant M Kocher


iScience ◽  
2021 ◽  
pp. 103322
Author(s):  
Kuniyo Sueyoshi ◽  
Daisuke Komura ◽  
Hiroto Katoh ◽  
Asami Yamamoto ◽  
Takumi Onoyama ◽  
...  


2021 ◽  
pp. 2104136
Author(s):  
Yuki Mizuta ◽  
Hitoshi Maeda ◽  
Yu Ishima ◽  
Yuki Minayoshi ◽  
Shota Ichimizu ◽  
...  


2021 ◽  
Vol 27 (24) ◽  
pp. 3483-3501
Author(s):  
Rachel Elizabeth Ann Fincham ◽  
Francesca Romana Delvecchio ◽  
Michelle R Goulart ◽  
Joe Poe Sheng Yeong ◽  
Hemant M Kocher




2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Yanxia Zhan ◽  
Junxian Du ◽  
Zhihui Min ◽  
Li Ma ◽  
Wei Zhang ◽  
...  

AbstractHypoxia is a common phenomenon in solid tumors. The roles of exosomes from hypoxic breast cancer stroma are less studied. So, the study was aimed to investigate the role of exosomes from hypoxic cancer-associated fibroblasts (CAFs) cells in breast cancer. The circRNA array analysis was performed to screen differential expressed circRNAs between hypoxic and normoxic CAFs exosomes. Candidate circHIF1A (circ_0032138) was screened out and it was confirmed that circHIF1A was up-regulated in the exosomes from hypoxic CAFs and their exosomes. Through investigating cellular functions including cell proliferation and stem cell features, it was demonstrated that hypoxic CAFs exosomes transferred circHIF1A into breast cancer cells, which played an important role in cancer stem cell properties sponging miR-580-5p by regulating CD44 expression. In a summary, circHIF1A from hypoxic CAFs exosomes played an important role in stem cell properties of breast cancer. CircHIF1A may act as a target molecule of breast cancer therapy.





2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Takuto Miyamura ◽  
Noriho Sakamoto ◽  
Kaori Ishida ◽  
Tomoyuki Kakugawa ◽  
Hirokazu Taniguchi ◽  
...  

Abstract Background Heat shock protein 47 (HSP47), a collagen-binding protein, has a specific role in the intracellular processing of procollagen production. HSP47 expression is associated with cancer growth and metastasis in several types of cancers. However, none of the studies have assessed whether HSP47 expression is associated with the risk of postoperative recurrence of lung cancer until now. Therefore, we aimed to assess this association. Methods The study population consisted of a cohort of consecutive patients who underwent surgery for lung cancer at Nagasaki University Hospital, Nagasaki, Japan, from January 2009 to December 2010. Patient characteristics, survival and disease-free survival (DFS), and laboratory findings were compared between patients who tested positive and negative for HSP47 expression in lung cancer cells and between those who showed high and low numbers of HSP47-positive fibroblasts in cancer stroma. Results A total of 133 patients underwent surgery for lung cancer. Sixty-seven patients (50.4%) had HSP47-positive cancer cells, and 91 patients (68.4%) had a higher number of HSP47-positive fibroblasts. The patients with a high number of HSP47-positive fibroblasts had a shorter DFS than those with a low number of HSP47-positive fibroblasts. Multivariate analysis identified only the presence of a high number of HSP47-positive fibroblasts as an independent risk factor for recurrence of lung cancer after surgery (odds ratio, 4.371; 95% confidence interval, 1.054–29.83; P = 0.042). Conclusion The present study demonstrated that the presence of a high number of HSP47-positive fibroblasts in the cancer stroma was a risk factor for recurrence of lung cancer after surgery.



2020 ◽  
Author(s):  
Takuto Miyamura ◽  
Noriho Sakamoto ◽  
Kaori Ishida ◽  
Tomoyuki Kakugawa ◽  
Hirokazu Taniguchi ◽  
...  

Abstract Background: Heat shock protein 47 (HSP47), a collagen-binding protein, has a specific role in the intracellular processing of procollagen production. HSP47 expression is associated with cancer growth and metastasis in several types of cancers. However, none of the studies have assessed whether HSP47 expression is associated with the risk of postoperative recurrence of lung cancer until now. Therefore, we aimed to assess this association.Methods: The study population consisted of a cohort of consecutive patients who underwent surgery for lung cancer at Nagasaki University Hospital, Nagasaki, Japan, from January 2009 to December 2010. Patient characteristics, survival and disease-free survival (DFS), and laboratory findings were compared between patients who tested positive and negative for HSP47 expression in lung cancer cells and between those who showed high and low numbers of HSP47-positive fibroblasts in cancer stroma.Results: A total of 133 patients underwent surgery for lung cancer. Sixty-seven patients (48.5%) had HSP47-positive cancer cells, and 91 patients (68.4%) had a higher number of HSP47-positive fibroblasts. The patients with a high number of HSP47-positive fibroblasts had a shorter DFS than those with a low number of HSP47-positive fibroblasts. Multivariate analysis identified only the presence of a high number of HSP47-positive fibroblasts as an independent risk factor for recurrence of lung cancer after surgery (odds ratio, 4.371; 95% confidence interval, 1.054–29.83; P = 0.042)Conclusion: The present study demonstrated that the presence of a high number of HSP47-positive fibroblasts in the cancer stroma was a risk factor for recurrence of lung cancer after surgery.



Oncotarget ◽  
2020 ◽  
Vol 11 (31) ◽  
pp. 2982-2994 ◽  
Author(s):  
Rina Fujiwara-Tani ◽  
Takamitsu Sasaki ◽  
Kiyomu Fujii ◽  
Yi Luo ◽  
Takuya Mori ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document